We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SPRC SciSparc Ltd

0.15 (1.92%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 530,904
Bid Price 7.98
Ask Price 8.55
News (1)
Day High 9.80


52 Week Range


Day Low 7.9604
Company Name Stock Ticker Symbol Market Type
SciSparc Ltd SPRC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.15 1.92% 7.96 19:50:53
Open Price Low Price High Price Close Price Prev Close
9.60 7.9604 9.80 7.96 7.81
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,039 530,904 $ 8.63 $ 4,579,447 - 2.80 - 34.58
Last Trade Time Type Quantity Stock Price Currency
19:57:47 10 $ 8.00 USD

SciSparc Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.16M 521.09k - 1.35M -2.59M -4.97 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

SciSparc News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SPRC Message Board. Create One! See More Posts on SPRC Message Board See More Message Board Posts

Historical SPRC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week8.1314.21997.8110.024,245,625-0.17-2.09%
1 Month5.4314.21994.188.192,663,1402.5346.59%
3 Months3.884414.21992.805.835,628,9044.08104.92%
6 Months17.1623.662.806.303,051,552-9.20-53.61%
1 Year27.5634.582.809.361,868,595-19.60-71.12%
3 Years182.00184.082.8021.061,633,162-174.04-95.63%
5 Years182.00184.082.8021.061,633,162-174.04-95.63%

SciSparc Description

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |